MICHELLE DOIG - 11 Aug 2025 Form 3 Insider Report for BridgeBio Oncology Therapeutics, Inc. (HLXB)

Role
Director
Signature
/s/ Aaron Chan, Attorney-in-Fact
Issuer symbol
HLXB
Transactions as of
11 Aug 2025
Net transactions value
$0
Form type
3
Filing time
18 Aug 2025, 17:19:10 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DOIG MICHELLE Director BRIDGEBIO ONCOLOGY THERAPEUTICS, INC., 256 EAST GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO /s/ Aaron Chan, Attorney-in-Fact 18 Aug 2025 0001832320

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney